Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
22,270,837
-
Shares change
-
-2,338,170
-
Total reported value, excl. options
-
$444,849,179
-
Value change
-
-$48,164,534
-
Put/Call ratio
-
95%
-
Number of buys
-
65
-
Number of sells
-
-58
-
Price
-
$19.97
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q2 2021
180 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q2 2021.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,270,837 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3,373,212 shares), STATE STREET CORP (2,656,584 shares), FMR LLC (2,576,471 shares), BlackRock Inc. (2,344,084 shares), JPMORGAN CHASE & CO (1,108,855 shares), MACQUARIE GROUP LTD (676,210 shares), Samsara BioCapital, LLC (640,688 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (613,888 shares), MORGAN STANLEY (574,805 shares), and TWO SIGMA ADVISERS, LP (497,600 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.